BioDelivery Sciences International, Inc.
(NASDAQ : BDSI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -8.91%44.040.0%$298.52m
HZNPHorizon Therapeutics Plc -3.87%99.725.4%$183.12m
VRXValeant Pharmaceuticals International, Inc. 0.04%23.4714.1%$138.10m
CTLTCatalent, Inc. -4.51%121.902.0%$135.04m
ICLRICON plc 0.43%274.222.8%$114.54m
UTHRUnited Therapeutics Corp. -2.65%184.2813.9%$76.71m
JAZZJazz Pharmaceuticals Plc -0.91%121.582.1%$74.90m
BHCBausch Health Cos., Inc. 0.04%23.470.0%$61.09m
PRGOPerrigo Co. Plc -0.01%35.836.9%$60.49m
ARGXargenx SE -2.04%288.900.0%$55.64m
CPIXCumberland Pharmaceuticals, Inc. 3.56%4.370.6%$49.60m
ENDPEndo International Plc -6.63%4.938.5%$43.53m
IRWDIronwood Pharmaceuticals, Inc. -1.44%10.959.5%$26.02m
PCRXPacira Biosciences, Inc. -0.60%53.439.8%$25.16m
QLGNQualigen Therapeutics, Inc. -8.71%1.210.0%$23.37m

Company Profile

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.